Theralase Technologies(TSE:TLT)
CA$0.190.00 (0.00%)
TSE:TLT
Theralase Technologies financials statements
CA$0.19
At close:0.00 (0.00%)
Want to see TSE:TLT full AI Analyst Report?
Theralase Technologies (TLT) Income Statement
99 Followers
Theralase Technologies Income Statement
Last quarter (Q2 2026), Theralase Technologies's total revenue was C$164.29K, a decrease of 25.23% from the same quarter last year. In Q2, Theralase Technologies's net income was C$-1.06M. See Theralase Technologies’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Mar 26 | Dec 24 | Dec 23 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| C$ 816.47K | C$ 1.03M | C$ 1.07M | C$ 1.14M | C$ 780.64K | |
| C$ 241.51K | C$ 554.03K | C$ 562.13K | C$ 628.17K | C$ 309.94K | |
| C$ 4.68M | C$ 4.84M | C$ 5.15M | C$ 5.86M | C$ 4.85M | |
| Depreciation and Amortization | C$ 265.62K | C$ 272.09K | C$ 286.12K | C$ 313.23K | C$ 276.15K |
| C$ -3.91M | C$ -3.96M | C$ -4.25M | C$ -4.90M | C$ -4.31M | |
| C$ -4.18M | C$ -4.29M | C$ -4.59M | C$ -5.20M | C$ -4.52M | |
| C$ 54.52K | C$ 32.23K | C$ 23.39K | C$ -3.76K | C$ 130.48K | |
| C$ -4.12M | C$ -4.26M | C$ -4.57M | C$ -5.24M | C$ -4.41M | |
| C$ -4.12M | C$ -4.26M | C$ -4.57M | C$ -5.25M | C$ -4.42M | |
| Per Share Metrics | |||||
| Basic EPS | C$ -0.02 | C$ -0.02 | C$ -0.02 | C$ -0.03 | C$ -0.02 |
| Diluted EPS | C$ -0.02 | C$ -0.02 | C$ -0.02 | C$ -0.03 | C$ -0.02 |
| Weighted Average Shares Outstanding | 253.13M | 240.07M | 219.97M | 207.92M | 204.28M |
| Weighted Average Shares Outstanding (Diluted) | 253.13M | 240.07M | 219.97M | 207.92M | 204.28M |
Currency in CAD

